BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October

Day

• 2
• 3
• 4
• 5
• 6
• 7
• 9
• 10
• 11
• 12
• 13
• 14
• 17
• 18
• 19
• 20
• 21
• 24
• 25
• 26
• 27
• 28

• 

  Press Releases

  Waldenstrom Macroglobulinemia Market Size to Reach USD 246.5 Million by 2035, Impelled by Advancements in Novel Therapies

  February 13, 2025

   · 

  11 min read
• 

  Press Releases

  West Syndrome Market Size to Reach USD 328.2 Million by 2034, Impelled by Development of New Antiepileptic Drugs (AEDS), Corticosteroids, and Hormonal Therapies

  February 13, 2025

   · 

  10 min read
• 

  Press Releases

  Scedosporium Infection Market Expected to Grow at a Steady CAGR of 5.9% during 2025-2035, Impelled by Rising Immunocompromised Population

  February 13, 2025

   · 

  6 min read
• 

  Press Releases

  Traveler’s Diarrhea Market Size to Reach USD 2,311.3 Million by 2035, Impelled by Advancements in Molecular Diagnostic Techniques

  February 13, 2025

   · 

  9 min read
• Press Releases

  Ipsen delivers solid results in 2024, driven by strong performance across all therapeutic areas, and provides guidance for 2025

  February 13, 2025

   · 

  8 min read
• Press Releases

  iLeadBMS Announces Orphan Drug Designation Granted by the FDA for IL21120033 (CXCR7 Agonist) for Idiopathic Pulmonary Fibrosis

  February 13, 2025

   · 

  1 min read
• Press Releases

  DAAN Biotherapeutics Signs Antibody Exclusive Licensing Agreement with LigaChem Biosciences for ADC (Antibody-Drug Conjugate) Therapeutic Development

  February 13, 2025

   · 

  1 min read
• Press Releases

  Cytovation Appoints Martin Dewhurst to its Board of Directors

  February 13, 2025

   · 

  2 min read
• Press Releases

  PulseSight Therapeutics Announces First Close of its Series A Financing to Fund Clinical Development of PST-611 in dry AMD

  February 13, 2025

   · 

  4 min read
• Press Releases

  Lindis Biotech and Pharmanovia Announce European Marketing Authorization Approval for Catumaxomab, A First-In-Class Treatment for Malignant Ascites

  February 13, 2025

   · 

  5 min read